Orbimed Advisors LLC Zymeworks Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$29.83 - $56.81 $9.46 Million - $18 Million	-317,002 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$39.12 - $54.99 $942,791 - $1.33 Million	-24,100 Reduced 7.07%	317,002 $15 Million
Q3 2020 Nov 16, 2020	SELL	$29.21 - $46.58 $7.05 Million - $11.2 Million	-241,200 Reduced 41.42%	341,102 $15.9 Million
Q1 2020 May 15, 2020	BUY	$24.28 - $49.8 $14.1 Million - $29 Million	582,302 New	582,302 $20.7 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $838M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.